Stocks
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -6.03 | 2.08 | 1.05 | 0.18 | -0.21 | 0.30 | ||
| Changes by years, y/y, % | -91% | -135% | -50% | -83% | -219% | -68.6% | |||
ALX Oncology Holdings. EV/EBITDA
ALX Oncology Holdings. EV/EBITDA, changes, %
ALX Oncology Holdings (ALXO) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 0.36 | -0.40 | -0.22 | -0.87 | -1.93 | 0.30 | |
| Changes by years, y/y, % | -56% | -237% | -198% | -302% | -637% | |||
| Changes by quarters, q/q, % | -16% | -210% | -45% | +295% | +123% | |||
